Shree Hari Chemicals Export Ltd Upgraded to Buy on Strong Financial and Quality Improvements

Financial Trend: A Very Positive Turnaround

The most compelling catalyst for the upgrade is the marked improvement in Shree Hari Chemicals’ financial trend. The company’s financial trend score surged from a flat 1 to a very positive 28 over the past three months, signalling robust operational momentum. In the quarter ended June 2026, the firm reported net sales of ₹96.13 crores, representing a remarkable growth rate of 61.97% compared to previous periods.

Operating profitability also hit new highs, with PBDIT reaching ₹8.48 crores and the operating profit margin climbing to 15.44%, the highest recorded for the company. Profit before tax excluding other income stood at ₹7.23 crores, while net profit after tax surged to ₹5.92 crores. Earnings per share (EPS) for the quarter rose to ₹9.38, underscoring the company’s enhanced earnings power.

Despite these gains, the return on capital employed (ROCE) for the half-year period remained relatively modest at 9.50%, indicating room for improvement in capital efficiency. Nonetheless, the overall financial trajectory is decidedly positive, justifying the upgrade in the financial grade and contributing significantly to the revised investment rating.

Quality Grade: From Below Average to Average

Alongside financial improvements, Shree Hari Chemicals’ quality grade has been upgraded from below average to average. This reflects solid five-year growth rates and improved operational metrics. The company’s sales have grown at a compound annual rate of 24.23% over five years, while EBIT growth has been even more impressive at 70.94% annually.

Financial stability indicators such as EBIT to interest coverage ratio (3.62) and debt to EBITDA ratio (3.93) remain within manageable levels, supporting the company’s creditworthiness. Net debt to equity stands at 0.64, indicating moderate leverage. The average return on capital employed (ROCE) and return on equity (ROE) are 11.17% and 12.62% respectively, signalling reasonable capital efficiency and shareholder returns.

Notably, the company has zero pledged shares and no institutional holding, which may be a consideration for some investors. However, the overall quality metrics place Shree Hari Chemicals in line with peers such as J.G. Chemicals and Titan Biotech, which also hold average quality grades within the commodity chemicals industry.

Valuation: Shift from Attractive to Fair

Valuation metrics have shifted from attractive to fair, reflecting the company’s improved fundamentals and rising share price. The price-to-earnings (PE) ratio currently stands at 9.22, which remains reasonable compared to many peers in the sector. The price-to-book value is 2.44, while enterprise value to EBIT and EBITDA ratios are 9.62 and 8.15 respectively, indicating a balanced valuation relative to earnings and cash flow.

Enterprise value to capital employed is a low 1.91, suggesting the stock is not overvalued relative to its asset base. The PEG ratio is exceptionally low at 0.06, highlighting the company’s strong earnings growth relative to its price. Latest ROCE and ROE figures of 6.07% and 9.30% respectively support the fair valuation assessment.

While the valuation is no longer classified as attractive, it remains compelling given the company’s growth prospects and improving financial health. This fair valuation grade aligns with the upgrade in the overall investment rating.

Technicals and Market Performance

Technically, Shree Hari Chemicals has demonstrated strong price momentum over multiple time horizons. Despite a 4.44% decline on the day of the rating change, the stock has delivered a 59.22% return over the past year, significantly outperforming the Sensex, which declined by 3.56% over the same period. Year-to-date returns stand at 30.53%, compared to a negative 8.79% for the benchmark index.

Longer-term performance is even more impressive, with three-year returns of 263.83% and five-year returns of 175.81%, dwarfing the Sensex’s respective gains of 19.30% and 39.32%. This consistent outperformance underscores the stock’s resilience and appeal to growth-oriented investors.

Promoter confidence has also strengthened, with promoters increasing their stake by 5.01% in the previous quarter to hold 64.26% of the company. This heightened promoter holding is a positive signal of management’s belief in the company’s future prospects.

Contextualising the Upgrade

The upgrade to a Buy rating with a Mojo Score of 74.0 reflects a comprehensive reassessment of Shree Hari Chemicals’ investment merits. The company’s micro-cap status and commodity chemicals sector positioning mean it is subject to cyclical and market volatility, but its recent financial results and quality improvements provide a strong foundation for future growth.

Its valuation remains fair, supported by a low PEG ratio and reasonable multiples, while technical momentum and promoter confidence add further conviction. Compared to industry peers, Shree Hari Chemicals stands out for its rapid profit growth and consistent outperformance versus the broader market indices.

Investors should note the company’s relatively modest ROCE and absence of institutional holdings, which may temper expectations for immediate re-rating. However, the positive financial trend and quality upgrade suggest that these metrics could improve over time as the company scales its operations and enhances capital efficiency.

Overall, the upgrade signals a favourable risk-reward profile for investors seeking exposure to the commodity chemicals sector through a fundamentally improving micro-cap stock with strong growth potential.

Summary

Shree Hari Chemicals Export Ltd’s investment rating upgrade from Hold to Buy is driven by:

• Very positive financial trend with strong quarterly sales and profit growth
• Improved quality grade reflecting solid five-year growth and manageable leverage
• Valuation shift from attractive to fair, supported by low PE and PEG ratios
• Robust technical performance and increased promoter stake signalling confidence

These factors combine to position the company as a compelling investment opportunity within the commodity chemicals sector, with a strong outlook for continued growth and value creation.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today